The PillCam™ Colon Capsule for Colon Cancer Screening: Comparison Between the First- and Second-Generation Capsules.
Population-based screening for colorectal cancer is widely recommended, with conventional colonoscopy (CC) being considered the preferred modality. However, compliance with colonoscopy screening is low, ranging between 20% and 50%, and manpower capacity for performing CC is limited. Therefore, a new, minimally invasive diagnostic tool, the PillCam™ Colon Capsule Endoscope (PCCE) was developed to become a desirable, patient-friendly, alternative strategy. This article will review the data regarding the 2 available generations of the PCCE.
Eliakim
Rami
R
Rappaport School of Medicine, Technion Israel Institute of Technology, Department of Medicine, Rambam Health Care Campus, Haifa, Israel. r_eliakim@rambam.health.gov.il
D000328:Adult; D000368:Aged; D053704:Capsule Endoscopy / Q000295:instrumentation*; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D055088:Early Detection of Cancer / Q000295:instrumentation*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies